Cara Therapeutics
CARA
#9640
Rank
S$21.59 M
Marketcap
$0.39
Share price
-4.32%
Change (1 day)
-75.76%
Change (1 year)

P/S ratio for Cara Therapeutics (CARA)

P/S ratio as of November 2024 (TTM): 1.46

According to Cara Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.39. At the end of 2024 the company had a P/S ratio of 1.28.

P/S ratio history for Cara Therapeutics from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.28-33.55%
20231.93-85.99%
202213.8-51.25%
202128.3406.59%
20205.58-85.25%
201937.8-0.84%
201838.2-91.29%
2017438-85.13%
2016> 10002339.11%
201512168.86%
201471.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
0.4811-67.11%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
22.4 1,431.32%๐Ÿ‡บ๐Ÿ‡ธ USA
2.88 96.59%๐Ÿ‡บ๐Ÿ‡ธ USA
4.41 201.49%๐Ÿ‡บ๐Ÿ‡ธ USA
0.0071-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA